Read More Pharma Industry News Zydus Group’s Sentynl Therapeutics gains full control of Menkes Disease candidate CUTX-101 Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company under Zydus Lifesciences, Ltd., has finalized an agreement with Cyprium Therapeutics,… byPallavi MadhirajuDecember 6, 2023